Berliner Boersenzeitung - US researchers seek to legitimize AI mental health care

EUR -
AED 4.31516
AFN 75.186175
ALL 95.293746
AMD 434.669939
ANG 2.102729
AOA 1078.452193
ARS 1630.2308
AUD 1.624055
AWG 2.116081
AZN 1.972096
BAM 1.949543
BBD 2.366794
BDT 144.45575
BGN 1.95966
BHD 0.443305
BIF 3494.983871
BMD 1.174784
BND 1.487719
BOB 8.119904
BRL 5.802732
BSD 1.175123
BTN 111.184676
BWP 15.724465
BYN 3.318535
BYR 23025.776091
BZD 2.363405
CAD 1.602048
CDF 2720.800684
CHF 0.915216
CLF 0.026764
CLP 1053.358606
CNY 8.00175
CNH 8.003695
COP 4381.253041
CRC 536.176843
CUC 1.174784
CUP 31.131789
CVE 110.371275
CZK 24.334502
DJF 208.783018
DKK 7.472646
DOP 69.958736
DZD 155.303645
EGP 61.942028
ERN 17.621767
ETB 184.561449
FJD 2.56679
FKP 0.865372
GBP 0.864271
GEL 3.159791
GGP 0.865372
GHS 13.216641
GIP 0.865372
GMD 86.346819
GNF 10314.60781
GTQ 8.970172
GYD 245.810019
HKD 9.204719
HNL 31.240732
HRK 7.535039
HTG 153.770943
HUF 357.845822
IDR 20346.562573
ILS 3.41111
IMP 0.865372
INR 111.018189
IQD 1538.967688
IRR 1542492.041252
ISK 143.805836
JEP 0.865372
JMD 185.157308
JOD 0.83289
JPY 183.801491
KES 151.759011
KGS 102.700249
KHR 4714.997648
KMF 492.234745
KPW 1057.310151
KRW 1699.372266
KWD 0.361786
KYD 0.979253
KZT 544.161183
LAK 25810.015627
LBP 105201.95124
LKR 376.191003
LRD 215.661076
LSL 19.425102
LTL 3.468833
LVL 0.710615
LYD 7.448409
MAD 10.806258
MDL 20.200081
MGA 4896.264456
MKD 61.652583
MMK 2466.517899
MNT 4205.316758
MOP 9.48422
MRU 46.876763
MUR 54.984854
MVR 18.156291
MWK 2046.474994
MXN 20.267324
MYR 4.610988
MZN 75.080436
NAD 19.425034
NGN 1600.056316
NIO 43.241033
NOK 10.928374
NPR 177.895283
NZD 1.972428
OMR 0.451734
PAB 1.175123
PEN 4.067693
PGK 5.109601
PHP 71.29591
PKR 327.500562
PLN 4.231549
PYG 7191.917329
QAR 4.280899
RON 5.267261
RSD 117.367963
RUB 87.820039
RWF 1715.185362
SAR 4.407583
SBD 9.436172
SCR 16.301074
SDG 705.462002
SEK 10.849505
SGD 1.490061
SHP 0.877095
SLE 28.958687
SLL 24634.638952
SOS 671.372647
SRD 43.949817
STD 24315.667154
STN 24.421514
SVC 10.281956
SYP 130.640379
SZL 19.149458
THB 37.85511
TJS 10.981508
TMT 4.11762
TND 3.414342
TOP 2.828599
TRY 53.113764
TTD 7.963407
TWD 36.875262
TZS 3045.25641
UAH 51.522813
UGX 4418.798927
USD 1.174784
UYU 47.218451
UZS 14189.398315
VES 579.75196
VND 30926.201816
VUV 138.918767
WST 3.198451
XAF 653.855648
XAG 0.01523
XAU 0.000251
XCD 3.174915
XCG 2.117894
XDR 0.818154
XOF 653.858422
XPF 119.331742
YER 280.332926
ZAR 19.270342
ZMK 10574.444756
ZMW 22.239527
ZWL 378.280128
  • RBGPF

    0.0800

    63.18

    +0.13%

  • RYCEF

    1.0500

    17.5

    +6%

  • CMSC

    0.0950

    22.975

    +0.41%

  • GSK

    0.3250

    50.705

    +0.64%

  • NGG

    0.2500

    87.89

    +0.28%

  • BTI

    0.3600

    59.76

    +0.6%

  • VOD

    0.3350

    16.075

    +2.08%

  • BCC

    2.3650

    74.495

    +3.17%

  • CMSD

    0.1200

    23.41

    +0.51%

  • RELX

    -0.3800

    35.78

    -1.06%

  • AZN

    3.8300

    185.07

    +2.07%

  • BP

    -1.7050

    44.795

    -3.81%

  • BCE

    -0.0250

    24.075

    -0.1%

  • RIO

    4.4950

    104.995

    +4.28%

  • JRI

    0.1100

    13.15

    +0.84%

US researchers seek to legitimize AI mental health care
US researchers seek to legitimize AI mental health care / Photo: Scott Eisen - GETTY IMAGES NORTH AMERICA/AFP/File

US researchers seek to legitimize AI mental health care

Researchers at Dartmouth College believe artificial intelligence can deliver reliable psychotherapy, distinguishing their work from the unproven and sometimes dubious mental health apps flooding today's market.

Text size:

Their application, Therabot, addresses the critical shortage of mental health professionals.

According to Nick Jacobson, an assistant professor of data science and psychiatry at Dartmouth, even multiplying the current number of therapists tenfold would leave too few to meet demand.

"We need something different to meet this large need," Jacobson told AFP.

The Dartmouth team recently published a clinical study demonstrating Therabot's effectiveness in helping people with anxiety, depression and eating disorders.

A new trial is planned to compare Therabot's results with conventional therapies.

The medical establishment appears receptive to such innovation.

Vaile Wright, senior director of health care innovation at the American Psychological Association (APA), described "a future where you will have an AI-generated chatbot rooted in science that is co-created by experts and developed for the purpose of addressing mental health."

Wright noted these applications "have a lot of promise, particularly if they are done responsibly and ethically," though she expressed concerns about potential harm to younger users.

Jacobson's team has so far dedicated close to six years to developing Therabot, with safety and effectiveness as primary goals.

Michael Heinz, psychiatrist and project co-leader, believes rushing for profit would compromise safety.

The Dartmouth team is prioritizing understanding how their digital therapist works and establishing trust.

They are also contemplating the creation of a nonprofit entity linked to Therabot to make digital therapy accessible to those who cannot afford conventional in-person help.

- Care or cash? -

With the cautious approach of its developers, Therabot could potentially be a standout in a marketplace of untested apps that claim to address loneliness, sadness and other issues.

According to Wright, many apps appear designed more to capture attention and generate revenue than improve mental health.

Such models keep people engaged by telling them what they want to hear, but young users often lack the savvy to realize they are being manipulated.

Darlene King, chair of the American Psychiatric Association's committee on mental health technology, acknowledged AI's potential for addressing mental health challenges but emphasizes the need for more information before determining true benefits and risks.

"There are still a lot of questions," King noted.

To minimize unexpected outcomes, the Therabot team went beyond mining therapy transcripts and training videos to fuel its AI app by manually creating simulated patient-caregiver conversations.

While the US Food and Drug Administration theoretically is responsible for regulating online mental health treatment, it does not certify medical devices or AI apps.

Instead, "the FDA may authorize their marketing after reviewing the appropriate pre-market submission," according to an agency spokesperson.

The FDA acknowledged that "digital mental health therapies have the potential to improve patient access to behavioral therapies."

- Therapist always in -

Herbert Bay, CEO of Earkick, defends his startup's AI therapist Panda as "super safe."

Bay says Earkick is conducting a clinical study of its digital therapist, which detects emotional crisis signs or suicidal ideation and sends help alerts.

"What happened with Character.AI couldn't happen with us," said Bay, referring to a Florida case in which a mother claims a chatbot relationship contributed to her 14-year-old son's death by suicide.

AI, for now, is suited more for day-to-day mental health support than life-shaking breakdowns, according to Bay.

"Calling your therapist at two in the morning is just not possible," but a therapy chatbot remains always available, Bay noted.

One user named Darren, who declined to provide his last name, found ChatGPT helpful in managing his traumatic stress disorder, despite the OpenAI assistant not being designed specifically for mental health.

"I feel like it's working for me," he said.

"I would recommend it to people who suffer from anxiety and are in distress."

(H.Schneide--BBZ)